📰 Dr Reddys Lab News
Dr Reddys Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dr Reddys Lab. Real-time updates on events, politics, business and more.
March 12, 2024
Pharma major Dr Reddys Laboratories Ltd received a tax demand with penalty of over Rs 74.22 crore from GST authority for wrongly availing credit of input tax. The company will file an appeal with the appellate authority in response to a regulatory filing.
November 20, 2023
Dr Reddys Lab price crosses above the 50-day moving average, and MACD gives a buy signal
November 16, 2023
In an interim order issued on Thursday, the Delhi High Court has restrained Smart Laboratories from utilizing the mark "Aziwake." The court ruled that this mark is allegedly deceptively similar to Dr Reddys Laboratories registered trademark "Aziwok," whether used with or without any prefixes or suffixes. The restriction applies specifically to pharmaceutical preparations and any other allied or cognate goods or services.
August 10, 2023
This article unveils the intriguing phenomenon of the Golden Crossover in stock trading. Highlighting data from a recent screener, we delve into 10 stocks that have witnessed the formation of a Golden Crossover pattern. Well provide a concise explanation of what the Golden Crossover is and discuss its significance in assessing stock movements.
July 6, 2023
Several stocks, including those of DLF, BPCL, Britannia, and Dr. Reddys Lab, hit new 52-week highs, leading to an impressive surge in the S&P BSE100 index. Godrej Consumer Products, Colgate-Palmolive, HDFC Life Insurance, Hero MotoCorp, HUL, and IndiGo also demonstrated strength and resilience in the Indian market.
March 12, 2023
The shares would be allotted under Dr. Reddy's Employees Stock Option Scheme, 2002.
May 20, 2022
Market watchers believe that low-level buying in beaten-down stocks supported the domestic equity market for the week ended May 20.
May 19, 2022
Covid-19 vaccine: Dr Reddys Lab to seek approval for Sputnik Light as universal booster dose - In September 2020, Dr. Reddys partnered with Russian Direct Investment Fund to conduct clinical trials of Sputnik V and distribute vaccine in India.
November 1, 2021
Markets open in green: Indices buoyant with Sensex up over 400 points, Nifty regains 17,800-mark
November 1, 2021
Trends on SGX Nifty indicate a positive opening for indices in India